SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Colby who wrote (218)4/17/1998 4:25:00 PM
From: BigKNY3  Read Replies (2) of 1016
 
Colby: Once again your post is much appreciated! Maybe we can actually combine these two Boards .....as they really should be.

I stand by my earlier VVUS and PFE predictions:

VVUS will ranged from 8 to 13 over the short term and will move with New Rx trends. 3/11/98 VVUS@ 11 1/4
Message 3715970

Message 3569244

OK, enough self-congratulation, what can I say to help you? Here are some ideas:

First, FDA approval of the production plant will be a non-event (unless the plant is rejected). Specification is the key now...not the ability to supply product.

I agree that one product will never take 100% of the ED market and that MUSE was a good product concept. Unfortunately , the current MUSE marketing plan is aimed to hold on to the #1 ED position and attack Viagra. The MUSE position was apparently lost during the last two weeks. Time for a new plan or new management.

Best of luck with your VVUS investment!

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext